Tenaya Therapeutics Inc. (TNYA)

AI Score

Unlock

0.48

0.04 (9.09%)

At close: Apr 11, 2025, 3:59 PM

0.47

-2.57%

After-hours: Apr 11, 2025, 05:53 PM EDT

Tenaya Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	4.32M	8.23M	58.13M	59.3M	45.68M	82.15M	75.56M	72.54M	95.27M	34.49M	31.01M	25.97M	38.13M	117.08M	111.89M	128.44M	128.53M	-26.63M
Short-Term Investments	57.12M	71.24M	41.17M	62.95M	58.96M	39.6M	56.94M	75.27M	91.25M	114.96M	149.91M	184.48M	213.17M	163.39M	n/a	n/a	n/a	53.25M
Long-Term Investments	n/a	n/a	419K	682K	682K	6.37M	19.14M	25.82M	17.7M	399K	399K	3.4M	-212.96M	559K	559K	634K	n/a	n/a
Other Long-Term Assets	4.82M	4.87M	4.64M	4.94M	4.99M	5.73M	5.54M	4.63M	4.79M	4.25M	3.71M	3.58M	214.63M	3.52M	5.89M	3.69M	1.01M	-26.63M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-19.95M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	842K	1.4M	1.41M	1.41M	1.16M	5.08M	6.4M	6.82M	7.23M	7.62M	4.78M	3.33M	n/a	4.36M	1.34M	n/a	n/a	n/a
Total Current Assets	67.38M	85.33M	105.03M	128.7M	111.58M	126.83M	138.91M	154.63M	193.75M	157.07M	185.69M	213.78M	255.36M	284.82M	113.22M	129.75M	129.96M	26.63M
Property-Plant & Equipment	47.75M	50.38M	53.09M	50.57M	53.26M	54.47M	57.17M	60.26M	62.7M	64.59M	66.13M	60.74M	54.7M	42.9M	37.23M	25.68M	17.18M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.46M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	52.56M	55.25M	58.16M	56.2M	58.93M	66.57M	81.85M	90.71M	85.19M	69.24M	70.24M	67.72M	58.83M	46.97M	43.67M	30.01M	18.2M	-26.63M
Total Assets	119.94M	140.58M	163.19M	184.9M	170.51M	193.4M	220.75M	245.34M	278.94M	226.31M	255.93M	281.5M	314.19M	331.79M	156.9M	159.76M	148.16M	n/a
Account Payables	5.16M	5.84M	4.32M	6.66M	5.63M	5.9M	8.48M	7.43M	9.58M	5.31M	5.35M	8.89M	10.72M	6.17M	5.02M	2.09M	1.02M	n/a
Deferred Revenue	n/a	n/a	836K	n/a	n/a	9.86M	8.21M	n/a	n/a	n/a	n/a	n/a	8.9M	5.09M	2.94M	1.99M	n/a	n/a
Short-Term Debt	n/a	n/a	3.36M	n/a	4.32M	3.15M	3.45M	n/a	n/a	4.02M	3.9M	2.08M	n/a	1.91M	1.64M	n/a	n/a	n/a
Other Current Liabilities	5.81M	5.37M	3.2M	1.54M	4.95M	4.11M	2.23M	1.5M	669K	1.08M	2.12M	3.66M	3.02M	1.26M	270K	241K	1.22M	n/a
Total Current Liabilities	15.97M	16.18M	16.71M	19.16M	22.73M	19.38M	20.92M	19.3M	24.25M	17.72M	18.74M	19.09M	21.77M	13.69M	9.8M	5.91M	5.04M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	281K	276K	266K	259K	253K	246K	240K	234K	228K	223K	217K	212K	182K	96K	240.74M	240.75M	224.44M	n/a
Total Long-Term Liabilities	11.11M	11.8M	12.48M	7.56M	8.36M	9.14M	9.9M	10.62M	11.32M	12.27M	13.32M	13.3M	13.89M	14.4M	255.63M	247.79M	224.44M	n/a
Total Liabilities	27.09M	27.98M	29.19M	26.72M	31.09M	28.51M	30.81M	245.34M	278.94M	29.98M	32.06M	32.4M	35.66M	28.09M	265.43M	253.7M	229.48M	n/a
Total Debt	13.61M	14.54M	15.57M	11.37M	12.42M	12.04M	13.1M	14.12M	15.1M	16.06M	17M	15.17M	13.71M	16.22M	16.53M	8.73M	n/a	n/a
Common Stock	8K	8K	8K	8K	7K	7K	7K	7K	7K	4K	4K	4K	4K	4K	12K	1K	n/a	n/a
Retained Earnings	-514.41M	-490.57M	-464.94M	-435.51M	-403.28M	-373.35M	-344.2M	-310.94M	-279.2M	-245.68M	-214.99M	-186.59M	-155.53M	-129.38M	-111.12M	-95.91M	-82.81M	n/a
Comprehensive Income	28K	76K	-67K	-120K	-106K	-261K	-333K	-120K	-378K	-767K	-739K	-631K	-141K	-23K	-12K	-87K	-87K	-43.74M
Shareholders Equity	92.85M	112.6M	134M	158.18M	139.42M	164.88M	189.94M	215.41M	243.38M	196.33M	223.87M	249.1M	278.53M	303.7M	-108.54M	-93.94M	-81.31M	29.3M
Total Investments	57.12M	71.24M	41.59M	63.63M	59.64M	45.97M	76.08M	101.09M	108.96M	114.96M	149.91M	184.48M	213.17K	163.39M	559K	634K	n/a	53.25M